Vanguard Group
LNAI

Vanguard Group’s Lunai Bioworks LNAI Stock Holding History

Vanguard Group’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$438K Sell
62,126
-2,577
-4% -$23K ﹤0.01% 3969
2025
Q3 		$735K Buy
64,703
+3,145
+5% +$60.6K ﹤0.01% 3865
2025
Q2 		$1.42M Sell
61,558
-9,196
-13% -$257K ﹤0.01% 3645
2025
Q1 		$3.07M Sell
70,754
-731
-1% -$46.8K ﹤0.01% 3341
2024
Q4 		$4.78M Sell
71,485
-10
-0% -$664 ﹤0.01% 3291
2024
Q3 		$2.76M Buy
71,495
+945
+1% +$65.5K ﹤0.01% 3452
2024
Q2 		$9.88M Buy
70,550
+21,592
+44% +$2.94M ﹤0.01% 2933
2024
Q1 		$10.4M Buy
48,958
+44,082
+904% +$11.9M ﹤0.01% 2946
2023
Q4 		$1.24M Buy
4,876
+1,484
+44% +$407K ﹤0.01% 3760
2023
Q3 		$1.21M Buy
3,392
+554
+20% +$84.2K ﹤0.01% 3762
2023
Q2 		$129K Sell
2,838
-1,190
-30% -$91.3K ﹤0.01% 4368
2023
Q1 		$295K Sell
4,028
-5,456
-58% -$480K ﹤0.01% 4254
2022
Q4 		$781K Buy
9,484
+44
+0.5% +$5.91K ﹤0.01% 3984
2022
Q3 		$1.37M Buy
9,440
+220
+2% +$40.1K ﹤0.01% 3893
2022
Q2 		$1.42M Sell
9,220
-2,483
-21% -$1.14M ﹤0.01% 3964
2022
Q1 		$7.72M Sell
11,703
-27
-0.2% -$14.4K ﹤0.01% 3286
2021
Q4 		$6.84M Buy
11,730
+8,517
+265% +$6.19M ﹤0.01% 3440
2021
Q3 		$1.73M Sell
3,213
-208
-6% -$102K ﹤0.01% 4103
2021
Q2 		$1.36M Sell
3,421
-658
-16% -$214K ﹤0.01% 4080
2021
Q1 		$1.16M Buy
4,079
+104
+3% +$30.6K ﹤0.01% 3982
2020
Q4 		$938K Buy
3,975
+78
+2% +$19.7K ﹤0.01% 3844
2020
Q3 		$1.12M Sell
3,897
-4,494
-54% -$1.42M ﹤0.01% 3634
2020
Q2 		$2.83M Sell
8,391
-78
-0.9% -$23.5K ﹤0.01% 3332
2020
Q1 		$2.03M Buy
8,469
+11
+0.1% +$3.27K ﹤0.01% 3314
2019
Q4 		$3.4M Buy
8,458
+2,032
+32% +$893K ﹤0.01% 3296
2019
Q3 		$2.83M Sell
6,426
-269
-4% -$103K ﹤0.01% 3334
2019
Q2 		$2.41M Buy
6,695
+338
+5% +$165K ﹤0.01% 3418
2019
Q1 		$3.53M Buy
+6,357
New +$3.71M ﹤0.01% 3269

Other funds holding LNAI

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Vanguard Group's LNAI Position: Q4 2025 in Review

Vanguard Group reduced its Lunai Bioworks (LNAI) stake by 4% in Q4 2025, selling an estimated $23K and leaving 62,126 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

Vanguard Group first reported a position in LNAI in Q1 2019 and has held it in 28 quarters since. The position peaked at $10.4M in Q1 2024. 22 funds tracked by Wall St. Rank hold LNAI as of Q4 2025.

  • Vanguard Group held 62,126 shares of Lunai Bioworks worth $438K as of Q4 2025.
  • Vanguard Group sold 2,577 Lunai Bioworks shares in Q4 2025, an estimated $23K.
  • Lunai Bioworks made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3969 holding.
  • Vanguard Group first reported a position in Lunai Bioworks in Q1 2019 and has held it in 28 quarters since.
  • Vanguard Group's Lunai Bioworks position peaked at $10.4M in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.